MY177164A - Attenuated bacteria for use in a vaccine - Google Patents
Attenuated bacteria for use in a vaccineInfo
- Publication number
- MY177164A MY177164A MYPI2012005702A MYPI2012005702A MY177164A MY 177164 A MY177164 A MY 177164A MY PI2012005702 A MYPI2012005702 A MY PI2012005702A MY PI2012005702 A MYPI2012005702 A MY PI2012005702A MY 177164 A MY177164 A MY 177164A
- Authority
- MY
- Malaysia
- Prior art keywords
- sequences
- polypeptide
- relates
- pasteurella
- bacteria
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 4
- 230000002238 attenuated effect Effects 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 241000606860 Pasteurella Species 0.000 abstract 3
- 230000036039 immunity Effects 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 241000282849 Ruminantia Species 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to an attenuated bacterium for use as a medicament which stimulates protective immunity against normal growth of pathogenic Pasteurella bacteria. The invention also relates to immunogenic preparations including vaccines against disease caused by infection by a virulent Pasteurella strain and tools for the generation of immunological and diagnostic reagents. Further, the present invention relates to live attenuated recombinant bacteria carrying a gene and vaccines based thereon that can be administered to animals, particularly ruminants to provide protective immunity against challenge by Pasteurella bacteria. Also disclosed are the bacterium polypeptide and includes polypeptide sequences, gene sequences encoding the polypeptide, vectors to contain the said sequences, and host cells transformed with the said vectors which include nucleotide sequences of the polypeptide sequences.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2012005702A MY177164A (en) | 2007-02-13 | 2007-02-13 | Attenuated bacteria for use in a vaccine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2012005702A MY177164A (en) | 2007-02-13 | 2007-02-13 | Attenuated bacteria for use in a vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY177164A true MY177164A (en) | 2020-09-08 |
Family
ID=79170403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2012005702A MY177164A (en) | 2007-02-13 | 2007-02-13 | Attenuated bacteria for use in a vaccine |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY177164A (en) |
-
2007
- 2007-02-13 MY MYPI2012005702A patent/MY177164A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dhama et al. | DNA vaccines and their applications in veterinary practice: current perspectives | |
| NZ586238A (en) | Methods and compositions for immunizing pigs against porcine circovirus | |
| DK2566507T3 (en) | Bioconjugate vaccines with capsular gram-positive bacteria | |
| CN102675471B (en) | Porcine Foot-and-Mouth Disease Virus Type O Broad Spectrum Multi-epitope Recombinant Antigen and Its Application | |
| US11103569B2 (en) | Vaccine for protection against Streptococcus suis | |
| WO2008039408A3 (en) | Live bacterial vaccines for viral infection prophylaxis or treatment | |
| MX2009006178A (en) | Salmonella vaccine. | |
| NZ597182A (en) | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response | |
| NZ597858A (en) | Vaccines and compositions against streptococcus pneumoniae | |
| MX2011011186A (en) | A tuberculosis tb vaccine to prevent reactivation. | |
| YU102103A (en) | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals | |
| US11696944B2 (en) | Vaccine for protection against Streptococcus suis | |
| BRPI0816134A2 (en) | Herpesvirus, DNA sequence, vector, cell, virus, method for producing infectious particles, infectious particles, vaccine, use of herpesvirus or DNA sequence or vector or infectious particles, and method for preventive and / or treatment. treatment of a disease. | |
| MD4481B1 (en) | Recombinant Koi herpesvirus (KHV) and vaccine for the prevention of a disease caused by KHV | |
| NZ598605A (en) | Vaccine against african horse sickness virus | |
| CN101775399A (en) | Asia1 type multi-epitope recombinant vaccine of bovine foot-and-mouth disease viruses and preparation method thereof | |
| CN103261214A (en) | Vaccines with live bacterial isolates for systemic administration | |
| CN101864434B (en) | Sheep aphthovirus Asial type multi-epitope recombinant vaccine and preparation method thereof | |
| WO2008058116A3 (en) | Tbpb proteins in attenuated oral live vaccines | |
| MY177164A (en) | Attenuated bacteria for use in a vaccine | |
| MY177159A (en) | Attenuated bacteria for use in a vaccine | |
| MY168662A (en) | Attenuated bacteria for use in a vaccine | |
| MY188912A (en) | Attenuated bacteria for use in a vaccine | |
| TN2014000393A1 (en) | Modified marek's disease virus, and vaccines made therefrom | |
| Dehvari et al. | Determination of Effective Prophylactic Responses of Truncated Flagellin Protein as a Vaccine Candidate Against Uropathogenic Escherichia coli |